Erly Sign Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 10

Erly Sign General Information

Description

Developer of oral cancer screening platforms designed to enable early detection of oral cancer through non-invasive testing. The company offers a platform that provides a painless and affordable home test kit with risk-level assessments, personalized lifestyle and dietary recommendations, follow-up consultations with nutritionists and doctors, scheduled retesting protocols, and educational resources, enabling individuals and healthcare providers to monitor oral health effectively and support timely medical intervention.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • House Number. 1087,khamla road,Near Tajshree honda
  • Ramkrishna nagar,Deo
  • Nagpur, Maharashtra 440015
  • India
+91 095457
Primary Industry
Diagnostic Equipment
Other Industries
Clinics/Outpatient Services
Biotechnology
Corporate Office
  • House Number. 1087,khamla road,Near Tajshree honda
  • Ramkrishna nagar,Deo
  • Nagpur, Maharashtra 440015
  • India
+91 095457

Erly Sign Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Erly Sign Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) 15-Jan-2025 $1.8M Completed Clinical Trials - Phase 4
5. Grant 01-Sep-2023 Completed Clinical Trials - Phase 4
4. Seed Round 27-Jun-2023 Completed Clinical Trials - Phase 4
3. Seed Round 01-Oct-2021 Completed Clinical Trials - Phase 4
2. Accelerator/Incubator 12-Apr-2021 Completed Startup
1. Angel (individual) 01-Aug-2019 Completed Startup
To view Erly Sign’s complete valuation and funding history, request access »

Erly Sign Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
To view Erly Sign’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Erly Sign Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oral cancer screening platforms designed to enable early detection of oral cancer through non-invasive test
Diagnostic Equipment
Nagpur, India
14 As of 2026

Palo Alto, CA
 

Lakeway, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Erly Sign Competitors (2)

One of Erly Sign’s 2 competitors is Delfi Diagnostics, a Venture Capital-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Delfi Diagnostics Venture Capital-Backed Palo Alto, CA
Vigilant Biosciences Venture Capital-Backed Lakeway, TX
You’re viewing 2 of 2 competitors. Get the full list »

Erly Sign Patents

Erly Sign Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11774450-B2 Apparatus for detection of proteolytic activity in a biological sample Active 21-Jan-2020
US-20210223245-A1 Apparatus for detection of proteolytic activity in a biological sample Active 21-Jan-2020

Erly Sign Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Erly Sign Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Amrita Technology Business Incubator Accelerator/Incubator
Anthill Ventures Venture Capital Minority
Founders Room Capital Angel Group Minority
Graycell Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Erly Sign FAQs

  • When was Erly Sign founded?

    Erly Sign was founded in 2019.

  • Where is Erly Sign headquartered?

    Erly Sign is headquartered in Nagpur, India.

  • What is the size of Erly Sign?

    Erly Sign has 14 total employees.

  • What industry is Erly Sign in?

    Erly Sign’s primary industry is Diagnostic Equipment.

  • Is Erly Sign a private or public company?

    Erly Sign is a Private company.

  • What is Erly Sign’s current revenue?

    The current revenue for Erly Sign is .

  • How much funding has Erly Sign raised over time?

    Erly Sign has raised $2.12M.

  • Who are Erly Sign’s investors?

    , Amrita Technology Business Incubator, Anthill Ventures, Founders Room Capital, and Graycell Ventures are 5 of 10 investors who have invested in Erly Sign.

  • Who are Erly Sign’s competitors?

    Delfi Diagnostics and Vigilant Biosciences are competitors of Erly Sign.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process